Johnson & Johnson tops expectations on earnings
Oct. 12, 2020 at 4:17 p.m. ETon Seeking AlphaOct. 12, 2020 at 12:10 p.m. ETon Seeking AlphaOct. 12, 2020 at 6:20 a.m. ETon Seeking AlphaOct. 11, 2020 at 10:16 a.m. ETon Seeking AlphaJohnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices.
The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
J&J Covid vaccine trial paused after volunteer takes illJohnson & Johnson temporarily pauses its Covid-19 vaccine trial after one of its 60,000 volunteers takes ill
Read more »
U.S. stock futures slip slightly as stimulus negotiations continueU.S. stock futures traded lower on Sunday night.
Read more »
Johnson & Johnson coronavirus vaccine trials paused - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Read more »
Johnson & Johnson pauses coronavirus vaccine trials after unexplained illnessThe drug maker announced Monday night that the 60,000-patient, late-stage trials have been put on hold and new enrollment has been halted, citing “an...
Read more »
Johnson & Johnson pauses clinical trials for a Covid vaccine over patient illnessThe trial was paused after an “unexplained” illness in one of its participants and in compliance with regulatory standards, the company said.
Read more »
Johnson & Johnson beats third-quarter earnings expectations, raises guidance
Read more »